COVID-19 has highlighted how healthcare and life sciences organizations are employing digital strategies to rapidly respond to immediate needs of the community. Despite the financial shock, both community and inpatient care had to be adapted quickly to address the increased demand on services. However, a care deficit developing, and revenue challenges are being realized. From myocardial infarction cases dropping to 70% in some regions, to the postponement of cancer screenings, there is a quietly developing curve of undiagnosed and deteriorating non-COVID disease. Response to the pandemic has magnified existing cracks in the system. Healthcare organizations have a choice – they can take a quick fix approach to the impending care and revenue tsunami, or this could be the opportunity to lay the foundation for a radical shift in care delivery.
- Is a pandemic the right time for long term investments? How to balance short terms needs with long term goals?
- How has Telehealth and Virtual Care evolved during the pandemic?
- What are the revenue considerations related to Telehealth and Virtual Care?
- The convergence of telehealth, personal devices and diagnostics platforms will enable patient care anywhere, anytime – What are early lessons learned?
- How will clinical care structures change to best utilize emerging technology?
- How can Providers, Pharma & Payors collaborate to deliver innovative care and business models?
- How can you deliver a seamless digital journey for both patients and care providers?
Dr. Calum MacRae, MD, PhD
Vice Chair for Scientific Innovation, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School
Director, Digital Health Program, Columbia Business School, Executive Education
Tatyana Popkova, MSM
Chief Strategy Officer,
Rush University System for Health